ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 121 filers reported holding ENDOLOGIX INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $45,000 | -85.5% | 61,762 | +12.7% | 0.00% | – |
| Q2 2018 | $310,000 | +201.0% | 54,784 | +183.9% | 0.00% | – |
| Q4 2017 | $103,000 | -67.2% | 19,300 | -72.6% | 0.00% | – |
| Q3 2017 | $314,000 | -34.3% | 70,385 | -28.4% | 0.00% | – |
| Q2 2017 | $478,000 | -73.4% | 98,300 | -60.4% | 0.00% | -100.0% |
| Q1 2017 | $1,798,000 | +108.6% | 248,300 | +64.6% | 0.00% | – |
| Q4 2016 | $862,000 | +257.7% | 150,811 | +424.2% | 0.00% | – |
| Q1 2016 | $241,000 | +57.5% | 28,772 | +130.2% | 0.00% | – |
| Q3 2015 | $153,000 | -29.2% | 12,500 | -11.1% | 0.00% | – |
| Q2 2015 | $216,000 | -22.0% | 14,063 | -13.3% | 0.00% | – |
| Q1 2015 | $277,000 | -76.3% | 16,217 | -78.8% | 0.00% | – |
| Q4 2014 | $1,168,000 | +57.0% | 76,369 | +56.0% | 0.00% | – |
| Q2 2014 | $744,000 | +89.8% | 48,955 | +60.6% | 0.00% | – |
| Q1 2014 | $392,000 | -28.6% | 30,479 | -3.2% | 0.00% | – |
| Q4 2013 | $549,000 | – | 31,475 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Capital Management, LLC | 4,050,000 | $49,653,000 | 5.91% |
| Essex Woodlands Management, Inc. | 1,257,468 | $21,220,000 | 3.88% |
| PURA VIDA INVESTMENTS, LLC | 205,100 | $2,515,000 | 1.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,347,113 | $28,776,000 | 1.11% |
| First Light Asset Management, LLC | 180,963 | $2,219,000 | 1.10% |
| ArrowMark Colorado Holdings LLC | 2,889,546 | $35,426,000 | 0.97% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,149,949 | $26,358,000 | 0.78% |
| Iguana Healthcare Management, LLC | 150,000 | $1,839,000 | 0.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,492,443 | $18,297,000 | 0.66% |
| WASHINGTON CAPITAL MANAGEMENT, INC | 85,882 | $1,053,000 | 0.66% |